Shattuck Labs Inc
NASDAQ:STTK

Watchlist Manager
Shattuck Labs Inc Logo
Shattuck Labs Inc
NASDAQ:STTK
Watchlist
Price: 1.33 USD 7.26% Market Closed
Market Cap: 63.5m USD
Have any thoughts about
Shattuck Labs Inc?
Write Note

Shattuck Labs Inc
Investor Relations

Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. The company is headquartered in Austin, Texas and currently employs 85 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of dual-sided fusion proteins. The firm has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected Checkpoint (ARC) platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the cluster of differentiation 47/signal regulatory protein alpha (CD47/SIRPa) checkpoint interaction to restore an anti-tumor immune response and to activate the cluster of differentiation 40 (CD40) costimulatory receptor to bolster an immune response. The firm's second product candidate, SL-279252, is designed to simultaneously inhibit the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction and activate the OX40 receptor.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Taylor H. Schreiber M.D., Ph.D.
Co-Founder, CEO & Director
No Bio Available
Mr. Andrew R. Neill M.B.A.
Chief Financial Officer
No Bio Available
Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.
Chief Medical Officer
No Bio Available
Dr. Abhinav A. Shukla Ph.D.
Chief Technical Officer
No Bio Available
Mr. Conor Richardson CPA
Vice President of Investor Relations
No Bio Available
Dr. Stephen Stout J.D., Ph.D.
General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer
No Bio Available
Ms. Casi DeYoung
Chief Business Officer
No Bio Available
Dr. Thomas Lampkin Pharm.D.
Senior Vice President of Regulatory Affairs
No Bio Available
Mr. Suresh de Silva Ph.D.
Co-Chief Scientific Officer
No Bio Available

Contacts

Address
TEXAS
Austin
500 W. 5Th Street, Suite 100
Contacts
+15129004690.0
www.shattucklabs.com